In addition, DLBCL patients with stage III-IV DLBCL and low SAMHD1 levels showed significantly improved OS compared to those with high SAMHD1 expression (P= 0.0074). This evidence concerns the gene SAMHD1 and diffuse large B-cell lymphoma.